A Study Called NATION-OS to Learn About the Link Between N-terminal proBNP (NT-proBNP) Levels and Medical Problems Due to Heart Failure (HF) in German Patients With HF (NATION-OS)
NT-proBNP Assessment in a HFrEF Population in Germany
Sponsor: Bayer
Listed as NCT04915118, this observational or N/A phase trial focuses on Heart Failure (HF) and remains completed. Sponsored by Bayer, it has been updated 10 times since 2021, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2023 — Jul 2024 [monthly]
Completed
-
Dec 2022 — Jan 2023 [monthly]
Completed
-
Mar 2022 — Dec 2022 [monthly]
Completed
▶ Show 5 earlier versions
-
Feb 2022 — Mar 2022 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Jan 2022 — Feb 2022 [monthly]
Active Not Recruiting
-
Dec 2021 — Jan 2022 [monthly]
Active Not Recruiting
-
Oct 2021 — Dec 2021 [monthly]
Active Not Recruiting
-
Sep 2021 — Oct 2021 [monthly]
Active Not Recruiting
First recorded
Jun 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Bayer
For direct contact, visit the study record on ClinicalTrials.gov .